Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-01 · accession 0001209191-23-034601 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-05 | 2023-06-01+ | RXRX | Virani Shafique | Chief Business Off | S - Sale | $8.73 | -42.9K | 161.8K | -21% | -$374.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-02 | S | D | 17,865 | $8.93 | 143,954 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-06-01 | S | D | 25,000 | $8.58 | 161,819 | D | — | — | (F2) Includes 1,717 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 22, 2023. |